Duratia: Clinically Proven Premature Ejaculation Management
| Product dosage: 30mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.23 | $36.98 (0%) | 🛒 Add to cart |
| 60 | $1.10 | $73.96 $66.22 (10%) | 🛒 Add to cart |
| 90 | $0.97 | $110.94 $87.72 (21%) | 🛒 Add to cart |
| 120 | $0.90 | $147.92 $107.50 (27%) | 🛒 Add to cart |
| 180 | $0.82 | $221.88 $147.06 (34%) | 🛒 Add to cart |
| 270 | $0.73 | $332.82 $197.80 (41%) | 🛒 Add to cart |
| 360 | $0.60
Best per pill | $443.76 $216.72 (51%) | 🛒 Add to cart |
| Product dosage: 60mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 10 | $3.70 | $36.98 (0%) | 🛒 Add to cart |
| 20 | $3.27 | $73.96 $65.36 (12%) | 🛒 Add to cart |
| 30 | $3.12 | $110.94 $93.74 (16%) | 🛒 Add to cart |
| 60 | $1.43 | $221.88 $86.00 (61%) | 🛒 Add to cart |
| 90 | $1.22 | $332.82 $110.08 (67%) | 🛒 Add to cart |
| 120 | $1.10 | $443.76 $132.44 (70%) | 🛒 Add to cart |
| 180 | $0.98 | $665.64 $176.30 (74%) | 🛒 Add to cart |
| 270 | $0.90 | $998.46 $241.66 (76%) | 🛒 Add to cart |
| 360 | $0.85
Best per pill | $1331.28 $306.16 (77%) | 🛒 Add to cart |
| Product dosage: 90mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 20 | $2.45 | $49.02 (0%) | 🛒 Add to cart |
| 30 | $1.83 | $73.53 $55.04 (25%) | 🛒 Add to cart |
| 60 | $1.63 | $147.06 $98.04 (33%) | 🛒 Add to cart |
| 90 | $1.51 | $220.59 $135.88 (38%) | 🛒 Add to cart |
| 120 | $1.43 | $294.12 $171.14 (42%) | 🛒 Add to cart |
| 180 | $1.34 | $441.18 $241.66 (45%) | 🛒 Add to cart |
| 270 | $1.30 | $661.77 $350.02 (47%) | 🛒 Add to cart |
| 360 | $1.26
Best per pill | $882.36 $452.36 (49%) | 🛒 Add to cart |
Duratia (dapoxetine hydrochloride) is a short-acting selective serotonin reuptake inhibitor (SSRI) specifically developed for the on-demand treatment of premature ejaculation (PE) in adult men. As the first and only oral medication approved for this indication in numerous countries, it represents a significant advancement in sexual medicine. Clinical trials demonstrate its ability to significantly increase intravaginal ejaculatory latency time (IELT) and improve patient-reported outcomes related to control over ejaculation and sexual satisfaction. The medication works by modulating serotonin neurotransmission in the central nervous system, which helps delay the ejaculatory reflex while maintaining normal erectile function and sexual desire.
Features
- Contains dapoxetine hydrochloride 30mg or 60mg as the active pharmaceutical ingredient
- Rapid absorption with peak plasma concentrations achieved within 1-2 hours post-administration
- Short elimination half-life of approximately 1.5-2 hours for reduced accumulation risk
- Designed for on-demand use rather than continuous daily dosing
- Available in film-coated tablet formulation for ease of administration
- Manufactured under strict pharmaceutical quality control standards
Benefits
- Significantly prolongs time to ejaculation, with clinical studies showing 2.5-3 times increase in IELT
- Provides predictable and reliable improvement in ejaculatory control with appropriate dosing
- Enhances sexual satisfaction for both partners through improved sexual performance
- Flexible dosing allows for administration 1-3 hours before anticipated sexual activity
- Minimal impact on erectile function or libido when used as directed
- Rapid clearance reduces the risk of next-day residual effects when taken properly
Common use
Duratia is specifically indicated for the treatment of premature ejaculation in adult men aged 18-64 years. The medication is intended for patients who meet the diagnostic criteria for lifelong or acquired premature ejaculation, characterized by persistent or recurrent ejaculation with minimal sexual stimulation before, on, or shortly after penetration and before the person wishes it. Clinical use typically involves men in stable sexual relationships who seek medical intervention for this condition. The medication is not indicated for use in women, adolescents, or men without a formal PE diagnosis.
Dosage and direction
The recommended starting dose is 30mg taken orally with water approximately 1-3 hours before anticipated sexual activity. The tablet should be swallowed whole without chewing or crushing. Based on efficacy and tolerability, the dose may be increased to 60mg if the 30mg dose is well-tolerated but provides insufficient effect. The maximum recommended dosing frequency is once every 24 hours. Patients should avoid taking Duratia with high-fat meals as this may increase absorption and potentially amplify side effects. Dose adjustment is recommended for patients with renal or hepatic impairment.
Precautions
Patients should be carefully evaluated before prescribing Duratia to exclude medical conditions that might mimic premature ejaculation. Caution is advised in patients with history of syncope, orthostatic hypotension, or conditions that might predispose to volume depletion. Regular monitoring of blood pressure is recommended, particularly during initial treatment. Patients should avoid sudden standing from sitting or lying positions to minimize orthostatic effects. Those with moderate hepatic impairment should not exceed the 30mg dose, while severe hepatic impairment contraindicates use. Concomitant alcohol consumption should be avoided due to increased risk of adverse events.
Contraindications
Duratia is contraindicated in patients with known hypersensitivity to dapoxetine or any excipients in the formulation. It must not be used in combination with monoamine oxidase inhibitors (MAOIs) or within 14 days of discontinuing MAOI therapy. Concomitant use with thioridazine or other potent CYP3A4 inhibitors is prohibited. The medication is contraindicated in patients with significant cardiac conditions including heart failure, conduction abnormalities, or significant ischemic heart disease. Use is prohibited in patients with history of mania or severe depression. Concurrent administration with other SSRIs, SNRIs, or tricyclic antidepressants is contraindicated.
Possible side effects
The most commonly reported adverse reactions include nausea (8.7-20.1%), dizziness (6.8-11.7%), headache (5.6-9.4%), diarrhea (3.9-6.8%), and insomnia (2.3-5.3%). These effects are generally mild to moderate and tend to decrease with continued use. Less frequent side effects may include fatigue, anxiety, blurred vision, tremors, and increased sweating. Syncope or pre-syncope has been reported in approximately 0.06-0.23% of patients. Priapism, while rare, requires immediate medical attention. Most adverse events are dose-dependent and more common with the 60mg dose.
Drug interaction
Dapoxetine is primarily metabolized by multiple CYP enzymes including CYP3A4, CYP2D6, and others. Concomitant use with potent CYP3A4 inhibitors (ketoconazole, ritonavir, clarithromycin) increases dapoxetine exposure approximately 2-3 fold and is contraindicated. Moderate CYP3A4 inhibitors should be used with caution. Concurrent administration with medications that increase serotonin levels (other SSRIs, SNRIs, triptans, tramadol) may increase risk of serotonin syndrome. Drugs that affect blood pressure or heart rate may potentiate orthostatic effects. CYP2D6 poor metabolizers may have increased dapoxetine exposure requiring dose adjustment.
Missed dose
As Duratia is taken on an as-needed basis rather than on a scheduled regimen, the concept of a “missed dose” does not apply in the conventional sense. If a patient forgets to take the medication before sexual activity, they should simply wait until their next anticipated sexual encounter to administer the medication. Patients should never double the dose to make up for a missed administration. The medication should only be taken when sexual activity is anticipated within the next 1-3 hours, and never more than once in a 24-hour period.
Overdose
Symptoms of overdose may include serotonin syndrome manifestations (agitation, confusion, diaphoresis, tachycardia, hyperthermia), syncope, dizziness, nausea, and vomiting. There is no specific antidote for dapoxetine overdose. Management should include supportive measures and symptomatic treatment. Gastric lavage may be considered if performed soon after ingestion. Activated charcoal may help reduce absorption. Patients should be monitored for cardiac abnormalities and orthostatic hypotension. Serotonin syndrome should be managed with supportive care and may require benzodiazepines, cyproheptadine, or cooling measures in severe cases.
Storage
Store at room temperature between 15-30°C (59-86°F) in the original packaging to protect from moisture and light. Keep the medication in a secure location out of reach of children and pets. Do not transfer tablets to alternative containers as the original packaging provides necessary protection. Do not use if the blister pack is damaged or tablets show signs of deterioration. Properly dispose of any expired medication according to local regulations. Avoid storage in bathrooms or other areas with high humidity.
Disclaimer
This information is provided for educational purposes only and does not constitute medical advice. Duratia is a prescription medication that should only be used under the supervision of a qualified healthcare professional. Patients should consult their physician for proper diagnosis and treatment recommendations. Individual results may vary, and not all patients will experience the same benefits. The medication should only be used by patients for whom it has been specifically prescribed. Always follow your healthcare provider’s instructions regarding use, dosage, and precautions.
Reviews
Clinical studies involving over 6,000 patients demonstrate that Duratia significantly improves IELT and patient-reported outcomes measures. In randomized controlled trials, approximately 70-80% of patients reported improved control over ejaculation and satisfaction with sexual intercourse compared to 20-30% in placebo groups. Real-world evidence from post-marketing surveillance supports the efficacy and safety profile observed in clinical trials. Patients report that the on-demand nature of treatment provides flexibility and convenience compared to daily dosing regimens. Most adverse events were described as manageable and diminished with continued use. Treatment satisfaction scores remain consistently high among appropriate candidates who follow prescribing guidelines.